Clinical trial
Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With…
NCT00055965 · The Christie NHS Foundation Trust, Other · Unknown status
Key facts
| NCT number | NCT00055965 |
|---|---|
| Title | Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin |
| Official title | A Pragmatic, Randomised Study To Compare The Hospitalisation Rates Of Two Platinum-Based Outpatient Regimens (Gemcitabine/Cisplatin vs. Gemcitabine/Carboplatin) In Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | The Christie NHS Foundation Trust, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, cisplatin, gemcitabine hydrochloride |
| Enrollment | 400 |
| Start date | Nov 1, 2002 |
| Primary completion | Aug 1, 2006 |
| First posted | Mar 7, 2003 |
| Last update posted | Sep 20, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: